Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28951 - 28975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	ANGPTL2	23452	upregulated	Dasatinib results in increased expression of ANGPTL2 mRNA	9q33.3	A21899
Dasatinib	Approved Investigational	ANKH	56172	upregulated	Dasatinib results in increased expression of ANKH mRNA	5p15.2	A21899
Dasatinib	Approved Investigational	ANLN	54443	downregulated	Dasatinib results in decreased expression of ANLN mRNA	7p14.2	A21899
Dasatinib	Approved Investigational	ANTXR1	84168	upregulated	Dasatinib results in increased expression of ANTXR1 mRNA	2p13.3	A21899
Dasatinib	Approved Investigational	AOX1	316	downregulated	Dasatinib results in decreased expression of AOX1 mRNA	2q33.1	A21899
Dasatinib	Approved Investigational	APOBEC3B	9582	downregulated	Dasatinib results in decreased expression of APOBEC3B mRNA	22q13.1	A21899
Dasatinib	Approved Investigational	ARHGAP11A	9824	downregulated	Dasatinib results in decreased expression of ARHGAP11A mRNA	15q13.3	A21899
Dasatinib	Approved Investigational	ARHGAP18	93663	downregulated	Dasatinib results in decreased expression of ARHGAP18 mRNA	6q22.33	A21899
Dasatinib	Approved Investigational	ARHGAP22	58504	downregulated	Dasatinib results in decreased expression of ARHGAP22 mRNA	10q11.22-q11.23	A21899
Dasatinib	Approved Investigational	ARMC9	80210	upregulated	Dasatinib results in increased expression of ARMC9 mRNA	2q37.1	A21899
Dasatinib	Approved Investigational	ARNTL2	56938	downregulated	Dasatinib results in decreased expression of ARNTL2 mRNA	12p11.23	A21899
Dasatinib	Approved Investigational	ASF1B	55723	downregulated	Dasatinib results in decreased expression of ASF1B mRNA	19p13.12	A21899
Dasatinib	Approved Investigational	ASNS	440	upregulated	Dasatinib results in increased expression of ASNS mRNA	7q21.3	A21899
Dasatinib	Approved Investigational	ASPM	259266	downregulated	Dasatinib results in decreased expression of ASPM mRNA	1q31.3	A21899
Dasatinib	Approved Investigational	ATAD2	29028	downregulated	Dasatinib results in decreased expression of ATAD2 mRNA	8q24.13	A21899
Dasatinib	Approved Investigational	ATAD5	79915	downregulated	Dasatinib results in decreased expression of ATAD5 mRNA	17q11.2	A21899
Dasatinib	Approved Investigational	AURKA	6790	downregulated	Dasatinib results in decreased expression of AURKA mRNA	20q13.2	A21899
Dasatinib	Approved Investigational	AURKB	9212	downregulated	Dasatinib results in decreased expression of AURKB mRNA	17p13.1	A21899
Dasatinib	Approved Investigational	BCL2	596	downregulated	Dasatinib results in decreased expression of BCL2 mRNA	18q21.33	A21900
Dasatinib	Approved Investigational	BGN	633	upregulated	Dasatinib results in increased expression of BGN mRNA	Xq28	A21899
Dasatinib	Approved Investigational	BIRC5	332	downregulated	Dasatinib results in decreased expression of BIRC5 mRNA	17q25.3	A21899
Dasatinib	Approved Investigational	BORA	79866	downregulated	Dasatinib results in decreased expression of BORA mRNA	13q21.33	A21899
Dasatinib	Approved Investigational	BRCA1	672	downregulated	Dasatinib results in decreased expression of BRCA1 mRNA	17q21.31	A21899
Dasatinib	Approved Investigational	BRCA2	675	downregulated	Dasatinib results in decreased expression of BRCA2 mRNA	13q13.1	A21899
Dasatinib	Approved Investigational	BUB1	699	downregulated	Dasatinib results in decreased expression of BUB1 mRNA	2q13	A21899

Displaying entries 28951 - 28975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability